A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cells

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

Michio Kawano, Toshio Hirano, Tadashi Matsuda et al. · Nature · 1988 · 1.7K citations

Medicine, Immunology, Oncology +11

A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay

S. Ansar Ahmed, Robert M. Gogal, Jane E. Walsh · Journal of Immunological Methods · 1994 · 1.4K citations

Life Sciences, Immunology, Clinical Immunology +4

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

James R. Berenson, Alan Lichtenstein, Lester Porter et al. · New England Journal of Medicine · 1996 · 1.1K citations

Medicine, Oncology, Pharmacotherapy +16

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

Masahiko Sato, W A Grasser, Naoto Endo et al. · Journal of Clinical Investigation · 1991 · 1K citations · Full text

Medicine, Endocrinology, Bone Augmentation +14

Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6

Bernard Klein, XG Zhang, M Jourdan et al. · Blood · 1989 · 755 citations · Full text

Life Sciences, Cell Biology, Oncology +11